Medicare and Medicaid will cover the bulk of that, spending $231 billion ... the disease and slow memory and cognitive decline. Biogen has discontinued one of those drugs, aducanumab, sold under ...

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Best whey-protein powders Best collagen-protein powder Best plant-based protein powders All the other protein powders I’ve tried Protein powders can be found in thousands of formulations on tens ...

Scroll through TikTok or Instagram and you’ll be inundated with protein-centric recipes. Maximizing protein is a huge trend right now on social media—and not just in the usual suspects ...

The best protein shakers are a must-buy, so we've tried and tested the best on the market to help you decide what to carry before, during and after your workouts. And we've done that much testing ...

SAN FRANCISCO (Reuters) - Biogen expects revenue from new launches ... an experimental drug that targets tau, a different protein found in the brains of Alzheimer's patients.

She has spent most of her career counseling patients with diabetes, across all ages. Creatine and protein both play essential roles in the body. Creatine is necessary for energy production and ...

Don’t overlook fruit when trying to add more protein to your diet. Fruit may not make the list of high-protein foods, but some options can provide the essential macronutrient, with the added ...

(Reuters) - Drugmaker Biogen will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece, a filing showed on Friday, sending the latter's stock up 34% in ...

After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on a range of strategic options. However, the company's board of directors ...